<img alt="" height="1" width="1" />
FDA Okays New Contrast Agent for Neuro MRIs
MedPage Today
A double-strength gadolinium contrast agent for neurological MRI scans, called gadobutrol (Gadavist), may now be marketed in the US, the FDA said. The approval followed a unanimous recommendation in January ...
FDA Approves Gadavist for Central Nervous System ScansPR Newswire (press release)
Bayer&#39;s Gadavist is sixth chemical for improving MRI scans approved in USCanadianBusiness.com
Bayer HealthCare Gadavist injection gets FDA approvalPharmaceutical Business Review
all 34 news articles &raquo;